Review




Structured Review

Pathwork Diagnostics Inc microarray-based gene expression diagnostic test
Microarray Based Gene Expression Diagnostic Test, supplied by Pathwork Diagnostics Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/microarray-based+gene+expression+diagnostic+test/gene+expression+profiling+pathwork+tissue+of+origin+test/pmc07791985-86-11-3
Average 90 stars, based on 1 article reviews
microarray-based gene expression diagnostic test - by Bioz Stars, 2026-09
90/100 stars

Images

Related Articles

Gene Expression:

Article Title: Evaluation of a Gene Expression Microarray-based Assay to Determine Tissue Type of Origin on a Diverse Set of 49 Malignancies
Article Snippet: .. Gene Expression Microarray Assay Gene expression profiling was performed following the Pathwork Diagnostics protocol as previously described. .. 4 In brief, total RNA was extracted from tumors using the RNeasy mini kit (Qiagen, Valencia, CA).

Microarray:

Article Title: Evaluation of a Gene Expression Microarray-based Assay to Determine Tissue Type of Origin on a Diverse Set of 49 Malignancies
Article Snippet: .. Gene Expression Microarray Assay Gene expression profiling was performed following the Pathwork Diagnostics protocol as previously described. .. 4 In brief, total RNA was extracted from tumors using the RNeasy mini kit (Qiagen, Valencia, CA).

Article Title: Cancer of Unknown Primary Site: Real Entity or Misdiagnosed Disease?
Article Snippet: .. However, the 1550-gene microarray-based Pathwork Tissue of Origin Test (Pathwork Diagnostics Inc., Redwood City, CA, USA) is the only test approved by the United States Food and Drug Administration , . ..

other:

Article Title: Gene expression array analysis to determine tissue of origin of carcinoma of unknown primary: cutting edge or already obsolete?
Article Snippet: In a recent edition of Cancer (Cancer Cytopathology), Stancel et al evaluated the feasibility of applying the Pathwork tissue-of-origin gene expression test (Pathwork Diagnostics, Redwood City, Calif) on cellblocks prepared from cytologic body fluid specimens.

Article Title: Transcriptomic analysis identifies organ-specific metastasis genes and pathways across different primary sites
Article Snippet: For example, the Pathwork Diagnostics® is a well-studied and clinically validated microarray-based gene expression diagnostic test for determining tissue of origin [ , ].

Article Title: Gene expression array analysis to determine tissue of origin of carcinoma of unknown primary: cutting edge or already obsolete?
Article Snippet: In a recent edition of Cancer (Cancer Cytopathology), Stancel et al6 evaluated the feasibility of applying the Pathwork tissue-of-origin gene expression test (Pathwork Diagnostics, Redwood City, Calif) on cellblocks prepared from cytologic body fluid specimens.

Article Title: Practical implications of gene-expression-based assays for breast oncologists
Article Snippet: Interestingly, a recent multisite reproducibility study of an FDA-approved microarray-based gene-expression test for identifying the tissue site of origin for tumors of unknown origins, known as Pathwork® (Pathwork Diagnostics, Redwood City, CA), obtained κ concordance values >0.81 when testing 149 paired samples.

Article Title: Exome-driven characterization of the cancer cell lines at the proteome level: the NCI-60 case study.
Article Snippet: Cancer genome deviates significantly from the reference human genome, and thus a search against standard genome databases in cancer cell proteomics fails to identify cancer-specific protein variants.. The goal of this Article is to combine high-throughput exome data [Abaan et al. Cancer Res.. 2013] and shotgun proteomics analysis [Modhaddas Gholami et al.

Diagnostic Assay:

Article Title: Occult Breast Cancer Presenting as Metastatic Adenocarcinoma of Unknown Primary: Clinical Presentation, Immunohistochemistry, and Molecular Analysis
Article Snippet: .. A microarray-based gene expression diagnostic test, the Pathwork TOO test (Pathwork Diagnostics), analyzes the expression of 1,550 genes by applying normalization and classification algorithms to gene expression data from a microarray. ..

Expressing:

Article Title: Occult Breast Cancer Presenting as Metastatic Adenocarcinoma of Unknown Primary: Clinical Presentation, Immunohistochemistry, and Molecular Analysis
Article Snippet: .. A microarray-based gene expression diagnostic test, the Pathwork TOO test (Pathwork Diagnostics), analyzes the expression of 1,550 genes by applying normalization and classification algorithms to gene expression data from a microarray. ..



Similar Products

90
Pathwork Diagnostics Inc microarray-based gene expression diagnostic test pathwork too test
Microarray Based Gene Expression Diagnostic Test Pathwork Too Test, supplied by Pathwork Diagnostics Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/microarray-based+gene+expression+diagnostic+test/gene+expression+profiling+pathwork+tissue+of+origin+test/pmc03290025-55-8-10
Average 90 stars, based on 1 article reviews
microarray-based gene expression diagnostic test pathwork too test - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
Pathwork Diagnostics Inc microarray-based gene expression diagnostic test
Microarray Based Gene Expression Diagnostic Test, supplied by Pathwork Diagnostics Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/microarray-based+gene+expression+diagnostic+test/gene+expression+profiling+pathwork+tissue+of+origin+test/pmc07791985-86-11-3
Average 90 stars, based on 1 article reviews
microarray-based gene expression diagnostic test - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
Pathwork Diagnostics Inc microarray-based gene expression diagnostic test pathwork® tissue of origin (too)
Microarray Based Gene Expression Diagnostic Test Pathwork® Tissue Of Origin (Too), supplied by Pathwork Diagnostics Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/microarray-based+gene+expression+diagnostic+test/gene+expression+profiling+pathwork+tissue+of+origin+test/pm21371531-206-11-13
Average 90 stars, based on 1 article reviews
microarray-based gene expression diagnostic test pathwork® tissue of origin (too) - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

Image Search Results